Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Karyopharm Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Karyopharm Therapeutics Inc. May 29, 202482.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 21, 2026 | Karyopharm Therapeutics Inc. | Grant or award | +15,508 | — | — |
| Aug 22, 2024 | Mereo BioPharma Group plc | Option exercise | +1,825 | $3.00 | $5,475 |
| Aug 22, 2024 | Mereo BioPharma Group plc | Option exercise | +6,492 | $1.84 | $11,945 |
| Aug 22, 2024 | Mereo BioPharma Group plc | Option exercise | +12,418 | $2.72 | $33,777 |
| Aug 22, 2024 | Mereo BioPharma Group plc | Option exercise | +38,953 | $1.31 | $51,028 |
| Aug 22, 2024 | Mereo BioPharma Group plc | Option exercise | +43,485 | $0.94 | $40,876 |
| Aug 22, 2024 | Mereo BioPharma Group plc | Option exercise | +2,071 | $3.87 | $8,015 |
| Aug 22, 2024 | Mereo BioPharma Group plc | Open-market sale | −105,244 | $4.43 | $466,231 |
| Jun 7, 2024 | Karyopharm Therapeutics Inc. | Open-market sale | −229,308 | $0.95 | $217,843 |
| Jun 7, 2024 | Karyopharm Therapeutics Inc. | Open-market sale | −2,240 | $0.95 | $2,128 |
| Jun 6, 2024 | Karyopharm Therapeutics Inc. | Open-market sale | −117,307 | $0.98 | $114,961 |
| Jun 6, 2024 | Karyopharm Therapeutics Inc. | Open-market sale | −1,145 | $0.98 | $1,122 |
| Jun 5, 2024 | Karyopharm Therapeutics Inc. | Open-market sale | −463,518 | $0.96 | $444,977 |
| Jun 5, 2024 | Karyopharm Therapeutics Inc. | Open-market sale | −4,526 | $0.96 | $4,345 |
| Jun 4, 2024 | Karyopharm Therapeutics Inc. | Open-market sale | −337,742 | $0.95 | $320,855 |
Questions about Deepika Pakianathan
What boards is Deepika Pakianathan on?
Deepika Pakianathan sits on the boards of Freenome Inc., Karyopharm Therapeutics Inc. and Mereo BioPharma Group plc.
How long has Deepika Pakianathan served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.